UniProt ID | EDC4_HUMAN | |
---|---|---|
UniProt AC | Q6P2E9 | |
Protein Name | Enhancer of mRNA-decapping protein 4 | |
Gene Name | EDC4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1401 | |
Subcellular Localization | Cytoplasm, P-body . Nucleus . | |
Protein Description | In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro).. | |
Protein Sequence | MASCASIDIEDATQHLRDILKLDRPAGGPSAESPRPSSAYNGDLNGLLVPDPLCSGDSTSANKTGLRTMPPINLQEKQVICLSGDDSSTCIGILAKEVEIVASSDSSISSKARGSNKVKIQPVAKYDWEQKYYYGNLIAVSNSFLAYAIRAANNGSAMVRVISVSTSERTLLKGFTGSVADLAFAHLNSPQLACLDEAGNLFVWRLALVNGKIQEEILVHIRQPEGTPLNHFRRIIWCPFIPEESEDCCEESSPTVALLHEDRAEVWDLDMLRSSHSTWPVDVSQIKQGFIVVKGHSTCLSEGALSPDGTVLATASHDGYVKFWQIYIEGQDEPRCLHEWKPHDGRPLSCLLFCDNHKKQDPDVPFWRFLITGADQNRELKMWCTVSWTCLQTIRFSPDIFSSVSVPPSLKVCLDLSAEYLILSDVQRKVLYVMELLQNQEEGHACFSSISEFLLTHPVLSFGIQVVSRCRLRHTEVLPAEEENDSLGADGTHGAGAMESAAGVLIKLFCVHTKALQDVQIRFQPQLNPDVVAPLPTHTAHEDFTFGESRPELGSEGLGSAAHGSQPDLRRIVELPAPADFLSLSSETKPKLMTPDAFMTPSASLQQITASPSSSSSGSSSSSSSSSSSLTAVSAMSSTSAVDPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKLTPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALSQDIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQLGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLAESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASASGGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQVAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVERALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLERSIRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSKNLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFRLGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATVAGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSIMQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNLVLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEEAVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLMLHGLVTPSLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASCASIDI ------CCCCCCCCH | 25.31 | 19413330 | |
3 | Phosphorylation | -----MASCASIDIE -----CCCCCCCCHH | 23.29 | 28122231 | |
6 | Phosphorylation | --MASCASIDIEDAT --CCCCCCCCHHHHH | 25.72 | 25159151 | |
13 | Phosphorylation | SIDIEDATQHLRDIL CCCHHHHHHHHHHHH | 28.92 | 26552605 | |
21 | Ubiquitination | QHLRDILKLDRPAGG HHHHHHHHCCCCCCC | 48.99 | 29967540 | |
30 | Phosphorylation | DRPAGGPSAESPRPS CCCCCCCCCCCCCCC | 48.20 | 23401153 | |
33 | Phosphorylation | AGGPSAESPRPSSAY CCCCCCCCCCCCCCC | 26.40 | 29255136 | |
37 | Phosphorylation | SAESPRPSSAYNGDL CCCCCCCCCCCCCCC | 28.96 | 25159151 | |
38 | Phosphorylation | AESPRPSSAYNGDLN CCCCCCCCCCCCCCC | 37.14 | 30576142 | |
40 | Phosphorylation | SPRPSSAYNGDLNGL CCCCCCCCCCCCCCE | 22.94 | 30576142 | |
55 | Phosphorylation | LVPDPLCSGDSTSAN ECCCCCCCCCCCCCC | 54.00 | 20068231 | |
58 | Phosphorylation | DPLCSGDSTSANKTG CCCCCCCCCCCCCCC | 27.99 | 20068231 | |
59 | Phosphorylation | PLCSGDSTSANKTGL CCCCCCCCCCCCCCC | 36.28 | 20068231 | |
60 | Phosphorylation | LCSGDSTSANKTGLR CCCCCCCCCCCCCCC | 33.52 | 25159151 | |
63 | Ubiquitination | GDSTSANKTGLRTMP CCCCCCCCCCCCCCC | 43.62 | 29967540 | |
64 | Phosphorylation | DSTSANKTGLRTMPP CCCCCCCCCCCCCCC | 41.05 | 23312004 | |
103 | Phosphorylation | KEVEIVASSDSSISS EEEEEEECCCCCCCC | 24.63 | 20068231 | |
104 | Phosphorylation | EVEIVASSDSSISSK EEEEEECCCCCCCCC | 31.60 | 20068231 | |
106 | Phosphorylation | EIVASSDSSISSKAR EEEECCCCCCCCCCC | 31.36 | 20068231 | |
107 | Phosphorylation | IVASSDSSISSKARG EEECCCCCCCCCCCC | 31.32 | 20068231 | |
109 | Phosphorylation | ASSDSSISSKARGSN ECCCCCCCCCCCCCC | 27.95 | 20068231 | |
110 | Phosphorylation | SSDSSISSKARGSNK CCCCCCCCCCCCCCC | 28.76 | 20068231 | |
111 | Ubiquitination | SDSSISSKARGSNKV CCCCCCCCCCCCCCC | 35.00 | 32015554 | |
119 | Ubiquitination | ARGSNKVKIQPVAKY CCCCCCCEEEECEEC | 36.91 | 29967540 | |
125 | Acetylation | VKIQPVAKYDWEQKY CEEEECEECCHHHCE | 43.93 | 19608861 | |
125 | Ubiquitination | VKIQPVAKYDWEQKY CEEEECEECCHHHCE | 43.93 | 22817900 | |
125 (in isoform 1) | Ubiquitination | - | 43.93 | 21890473 | |
126 | Phosphorylation | KIQPVAKYDWEQKYY EEEECEECCHHHCEE | 19.29 | 22817900 | |
147 | Phosphorylation | VSNSFLAYAIRAANN ECHHHHHHHHHHHHC | 12.52 | 22817900 | |
165 | Phosphorylation | MVRVISVSTSERTLL EEEEEEEECCCCHHH | 21.30 | 22210691 | |
166 | Phosphorylation | VRVISVSTSERTLLK EEEEEEECCCCHHHC | 32.24 | 22210691 | |
170 | Phosphorylation | SVSTSERTLLKGFTG EEECCCCHHHCCCCC | 32.18 | 22210691 | |
287 | Ubiquitination | PVDVSQIKQGFIVVK CCCHHHCCCCEEEEE | 36.41 | - | |
359 | Ubiquitination | LFCDNHKKQDPDVPF EEECCCCCCCCCCCH | 53.00 | 29967540 | |
385 | Phosphorylation | RELKMWCTVSWTCLQ CEEEHHHEEEHHHHH | 11.32 | 24043423 | |
387 | Phosphorylation | LKMWCTVSWTCLQTI EEHHHEEEHHHHHHH | 9.87 | 24043423 | |
389 | Phosphorylation | MWCTVSWTCLQTIRF HHHEEEHHHHHHHCC | 8.88 | 24043423 | |
393 | Phosphorylation | VSWTCLQTIRFSPDI EEHHHHHHHCCCCCH | 10.94 | 24043423 | |
405 | Phosphorylation | PDIFSSVSVPPSLKV CCHHHCCCCCCCHHH | 30.74 | - | |
409 | Phosphorylation | SSVSVPPSLKVCLDL HCCCCCCCHHHHHHH | 34.45 | 20068231 | |
475 | Phosphorylation | SRCRLRHTEVLPAEE HCCCCCCCEEECCHH | 22.73 | 20068231 | |
486 | Phosphorylation | PAEEENDSLGADGTH CCHHHCCCCCCCCCC | 40.04 | 23401153 | |
492 | Phosphorylation | DSLGADGTHGAGAME CCCCCCCCCCHHHHH | 20.06 | 28192239 | |
500 | Phosphorylation | HGAGAMESAAGVLIK CCHHHHHHHHHHHHH | 15.44 | 23401153 | |
514 | Acetylation | KLFCVHTKALQDVQI HHHHHHCCHHCCCHH | 32.02 | 26051181 | |
537 | Phosphorylation | DVVAPLPTHTAHEDF CCEECCCCCCCCCCC | 39.27 | 26330541 | |
539 | Phosphorylation | VAPLPTHTAHEDFTF EECCCCCCCCCCCCC | 31.99 | 26330541 | |
545 | Phosphorylation | HTAHEDFTFGESRPE CCCCCCCCCCCCCCC | 42.95 | 26074081 | |
549 | Phosphorylation | EDFTFGESRPELGSE CCCCCCCCCCCCCCC | 54.22 | 26074081 | |
555 | Phosphorylation | ESRPELGSEGLGSAA CCCCCCCCCCCCHHC | 40.91 | 29255136 | |
560 | Phosphorylation | LGSEGLGSAAHGSQP CCCCCCCHHCCCCCC | 27.59 | 29255136 | |
565 | Phosphorylation | LGSAAHGSQPDLRRI CCHHCCCCCCCHHHH | 28.77 | 29255136 | |
583 | Phosphorylation | PAPADFLSLSSETKP CCCCCHHCCCCCCCC | 26.63 | 24972180 | |
585 | Phosphorylation | PADFLSLSSETKPKL CCCHHCCCCCCCCCC | 23.81 | 25159151 | |
586 | Phosphorylation | ADFLSLSSETKPKLM CCHHCCCCCCCCCCC | 55.36 | 26055452 | |
588 | Phosphorylation | FLSLSSETKPKLMTP HHCCCCCCCCCCCCC | 55.37 | 25159151 | |
589 | Acetylation | LSLSSETKPKLMTPD HCCCCCCCCCCCCCC | 35.78 | 26051181 | |
589 | Ubiquitination | LSLSSETKPKLMTPD HCCCCCCCCCCCCCC | 35.78 | - | |
594 | Phosphorylation | ETKPKLMTPDAFMTP CCCCCCCCCCCCCCC | 28.58 | 26074081 | |
613 | Phosphorylation | QQITASPSSSSSGSS HHHHCCCCCCCCCCC | 40.12 | - | |
621 | Phosphorylation | SSSSGSSSSSSSSSS CCCCCCCCCCCCCCC | 35.62 | - | |
622 | Phosphorylation | SSSGSSSSSSSSSSS CCCCCCCCCCCCCCC | 35.87 | - | |
623 | Phosphorylation | SSGSSSSSSSSSSSL CCCCCCCCCCCCCCC | 35.87 | - | |
624 | Phosphorylation | SGSSSSSSSSSSSLT CCCCCCCCCCCCCCH | 35.87 | - | |
640 | O-linked_Glycosylation | VSAMSSTSAVDPSLT HHCCCCCCCCCHHHC | 28.39 | OGP | |
645 | Phosphorylation | STSAVDPSLTRPPEE CCCCCCHHHCCCCHH | 37.60 | 21406692 | |
647 | Phosphorylation | SAVDPSLTRPPEELT CCCCHHHCCCCHHCC | 45.53 | 21406692 | |
654 | Phosphorylation | TRPPEELTLSPKLQL CCCCHHCCCCCCEEE | 28.59 | 26074081 | |
656 | Phosphorylation | PPEELTLSPKLQLDG CCHHCCCCCCEEECC | 18.11 | 26657352 | |
664 | Phosphorylation | PKLQLDGSLTMSSSG CCEEECCCEEECCCC | 21.97 | 26055452 | |
666 | Phosphorylation | LQLDGSLTMSSSGSL EEECCCEEECCCCCC | 19.39 | 27732954 | |
668 | Phosphorylation | LDGSLTMSSSGSLQA ECCCEEECCCCCCCC | 19.00 | 22199227 | |
669 | Phosphorylation | DGSLTMSSSGSLQAS CCCEEECCCCCCCCC | 28.09 | 22199227 | |
670 | Phosphorylation | GSLTMSSSGSLQASP CCEEECCCCCCCCCC | 25.70 | 22199227 | |
672 | Phosphorylation | LTMSSSGSLQASPRG EEECCCCCCCCCCCC | 21.18 | 22199227 | |
676 | Phosphorylation | SSGSLQASPRGLLPG CCCCCCCCCCCCCCC | 11.36 | 25159151 | |
691 | Acetylation | LLPAPADKLTPKGPG CCCCCHHHCCCCCCC | 57.26 | 25953088 | |
693 | Phosphorylation | PAPADKLTPKGPGQV CCCHHHCCCCCCCCC | 28.79 | 30266825 | |
702 | Phosphorylation | KGPGQVPTATSALSL CCCCCCCCHHHEEEE | 43.65 | 30278072 | |
704 | Phosphorylation | PGQVPTATSALSLEL CCCCCCHHHEEEEEE | 19.60 | 28176443 | |
705 | Phosphorylation | GQVPTATSALSLELQ CCCCCHHHEEEEEEE | 25.42 | 28176443 | |
708 | Phosphorylation | PTATSALSLELQEVE CCHHHEEEEEEEECC | 21.36 | 30278072 | |
723 | Phosphorylation | PLGLPQASPSRTRSP CCCCCCCCCCCCCCH | 20.40 | 29255136 | |
725 | Phosphorylation | GLPQASPSRTRSPDV CCCCCCCCCCCCHHH | 43.73 | 29255136 | |
727 | Phosphorylation | PQASPSRTRSPDVIS CCCCCCCCCCHHHHH | 39.58 | 22167270 | |
729 | Phosphorylation | ASPSRTRSPDVISSA CCCCCCCCHHHHHHH | 25.49 | 19664994 | |
734 | Phosphorylation | TRSPDVISSASTALS CCCHHHHHHHHHHHH | 21.50 | 22167270 | |
735 | Phosphorylation | RSPDVISSASTALSQ CCHHHHHHHHHHHHC | 18.34 | 26846344 | |
737 | Phosphorylation | PDVISSASTALSQDI HHHHHHHHHHHHCCH | 19.03 | 26846344 | |
738 | Phosphorylation | DVISSASTALSQDIP HHHHHHHHHHHCCHH | 31.19 | 26846344 | |
741 | Phosphorylation | SSASTALSQDIPEIA HHHHHHHHCCHHHHH | 24.28 | 26846344 | |
749 | Phosphorylation | QDIPEIASEALSRGF CCHHHHHHHHHHCCC | 29.12 | 23927012 | |
753 | Phosphorylation | EIASEALSRGFGSSA HHHHHHHHCCCCCCC | 37.09 | 23927012 | |
758 | Phosphorylation | ALSRGFGSSAPEGLE HHHCCCCCCCCCCCC | 22.52 | 25850435 | |
759 | Phosphorylation | LSRGFGSSAPEGLEP HHCCCCCCCCCCCCC | 48.50 | 25850435 | |
768 | Phosphorylation | PEGLEPDSMASAASA CCCCCCCHHHHHHHH | 27.28 | 27794612 | |
771 | Phosphorylation | LEPDSMASAASALHL CCCCHHHHHHHHHHH | 18.74 | 27794612 | |
774 | Phosphorylation | DSMASAASALHLLSP CHHHHHHHHHHHHCC | 30.95 | 26055452 | |
780 | Phosphorylation | ASALHLLSPRPRPGP HHHHHHHCCCCCCCC | 25.81 | 29255136 | |
807 | Phosphorylation | GDGDRHNTPSLLEAA CCCCCCCCHHHHHHH | 14.23 | 26055452 | |
809 | Phosphorylation | GDRHNTPSLLEAALT CCCCCCHHHHHHHHH | 43.48 | 21712546 | |
816 | Phosphorylation | SLLEAALTQEASTPD HHHHHHHHHCCCCCC | 21.45 | 20873877 | |
820 | Phosphorylation | AALTQEASTPDSQVW HHHHHCCCCCCHHHC | 39.46 | 25159151 | |
821 | Phosphorylation | ALTQEASTPDSQVWP HHHHCCCCCCHHHCC | 37.86 | 25159151 | |
824 | Phosphorylation | QEASTPDSQVWPTAP HCCCCCCHHHCCCCC | 28.04 | 20873877 | |
829 | Phosphorylation | PDSQVWPTAPDITRE CCHHHCCCCCCCCHH | 34.80 | 20068231 | |
834 | Phosphorylation | WPTAPDITRETCSTL CCCCCCCCHHHHHHH | 29.81 | 20068231 | |
837 | Phosphorylation | APDITRETCSTLAES CCCCCHHHHHHHHHC | 14.41 | 23898821 | |
839 | Phosphorylation | DITRETCSTLAESPR CCCHHHHHHHHHCCC | 33.60 | 25159151 | |
840 | Phosphorylation | ITRETCSTLAESPRN CCHHHHHHHHHCCCC | 31.94 | 30266825 | |
844 | Phosphorylation | TCSTLAESPRNGLQE HHHHHHHCCCCCHHH | 24.45 | 19664994 | |
855 | Phosphorylation | GLQEKHKSLAFHRPP CHHHHHHHHHHCCCC | 25.34 | 28348404 | |
863 | Phosphorylation | LAFHRPPYHLLQQRD HHHCCCCHHHHCCCC | 14.05 | 28796482 | |
871 | Phosphorylation | HLLQQRDSQDASAEQ HHHCCCCCCCCCHHH | 31.95 | 23927012 | |
875 | Phosphorylation | QRDSQDASAEQSDHD CCCCCCCCHHHCCCH | 40.40 | 20201521 | |
879 | Phosphorylation | QDASAEQSDHDDEVA CCCCHHHCCCHHHHH | 28.55 | 20201521 | |
887 | Phosphorylation | DHDDEVASLASASGG CCHHHHHHHHHHCCC | 29.64 | 23927012 | |
887 (in isoform 2) | Ubiquitination | - | 29.64 | 21906983 | |
890 | Phosphorylation | DEVASLASASGGFGT HHHHHHHHHCCCCCC | 28.41 | 30278072 | |
892 | Phosphorylation | VASLASASGGFGTKV HHHHHHHCCCCCCCC | 36.63 | 23927012 | |
897 | Phosphorylation | SASGGFGTKVPAPRL HHCCCCCCCCCCCCC | 26.97 | 23927012 | |
907 | Acetylation | PAPRLPAKDWKTKGS CCCCCCCCCCCCCCC | 63.28 | 25953088 | |
911 | Phosphorylation | LPAKDWKTKGSPRTS CCCCCCCCCCCCCCC | 36.06 | 20363803 | |
914 | Phosphorylation | KDWKTKGSPRTSPKL CCCCCCCCCCCCHHH | 16.86 | 28102081 | |
917 | Phosphorylation | KTKGSPRTSPKLKRK CCCCCCCCCHHHCCC | 53.41 | 30576142 | |
918 | Phosphorylation | TKGSPRTSPKLKRKS CCCCCCCCHHHCCCC | 22.71 | 28102081 | |
925 | Phosphorylation | SPKLKRKSKKDDGDA CHHHCCCCCCCCCCC | 49.31 | 21406692 | |
926 | Ubiquitination | PKLKRKSKKDDGDAA HHHCCCCCCCCCCCC | 64.36 | 24816145 | |
936 | Phosphorylation | DGDAAMGSRLTEHQV CCCCCHHCCCCCCCC | 15.84 | 21406692 | |
965 | Methylation | QRELAELRHSQEELL HHHHHHHHHCHHHHH | 20.93 | - | |
967 | Phosphorylation | ELAELRHSQEELLQR HHHHHHHCHHHHHHH | 32.62 | 20873877 | |
977 | Phosphorylation | ELLQRLCTQLEGLQS HHHHHHHHHHHHHHH | 40.56 | 24719451 | |
1015 | Methylation | ALAEGQQRGGQLQEQ HHHHHHHHHHHHHHH | 43.23 | - | |
1042 | Phosphorylation | VAGRLERSIRDEIKK HHHHHHHHHHHHHHH | 16.76 | 23898821 | |
1049 | Ubiquitination | SIRDEIKKTVPPCVS HHHHHHHHHCCCCHH | 61.49 | 24816145 | |
1050 | Phosphorylation | IRDEIKKTVPPCVSR HHHHHHHHCCCCHHH | 32.99 | 27470641 | |
1058 | Phosphorylation | VPPCVSRSLEPMAGQ CCCCHHHCCCCCCHH | 29.58 | 23612710 | |
1062 | Sulfoxidation | VSRSLEPMAGQLSNS HHHCCCCCCHHCHHH | 4.83 | 21406390 | |
1067 | Phosphorylation | EPMAGQLSNSVATKL CCCCHHCHHHHHHHH | 21.12 | 20068231 | |
1069 | Phosphorylation | MAGQLSNSVATKLTA CCHHCHHHHHHHHHH | 15.11 | 20068231 | |
1072 | Phosphorylation | QLSNSVATKLTAVEG HCHHHHHHHHHHCCC | 25.16 | 20068231 | |
1075 | Phosphorylation | NSVATKLTAVEGSMK HHHHHHHHHCCCHHH | 30.16 | 22673903 | |
1080 | Phosphorylation | KLTAVEGSMKENISK HHHHCCCHHHHHHHH | 17.11 | 22673903 | |
1082 | Ubiquitination | TAVEGSMKENISKLL HHCCCHHHHHHHHHH | 49.67 | - | |
1087 | Acetylation | SMKENISKLLKSKNL HHHHHHHHHHHCCCH | 54.78 | 25953088 | |
1087 | Malonylation | SMKENISKLLKSKNL HHHHHHHHHHHCCCH | 54.78 | 26320211 | |
1087 | Ubiquitination | SMKENISKLLKSKNL HHHHHHHHHHHCCCH | 54.78 | 29967540 | |
1092 | 2-Hydroxyisobutyrylation | ISKLLKSKNLTDAIA HHHHHHCCCHHHHHH | 55.15 | - | |
1092 | Malonylation | ISKLLKSKNLTDAIA HHHHHHCCCHHHHHH | 55.15 | 26320211 | |
1092 | Ubiquitination | ISKLLKSKNLTDAIA HHHHHHCCCHHHHHH | 55.15 | 29967540 | |
1148 | Phosphorylation | FRLGTQEYLQQLESH HHHCHHHHHHHHHHH | 10.45 | 28555341 | |
1154 | Phosphorylation | EYLQQLESHMKSRKA HHHHHHHHHHHHHHH | 37.16 | 25159151 | |
1157 | Acetylation | QQLESHMKSRKAREQ HHHHHHHHHHHHHHH | 41.50 | 25953088 | |
1157 | Ubiquitination | QQLESHMKSRKAREQ HHHHHHHHHHHHHHH | 41.50 | 23000965 | |
1157 (in isoform 1) | Ubiquitination | - | 41.50 | 21890473 | |
1158 | Phosphorylation | QLESHMKSRKAREQE HHHHHHHHHHHHHHH | 31.29 | 28857561 | |
1160 | Ubiquitination | ESHMKSRKAREQEAR HHHHHHHHHHHHHHH | 59.91 | 23000965 | |
1248 | Phosphorylation | SIMQAMRSAAGTPVP HHHHHHHHHCCCCCC | 14.91 | 26657352 | |
1252 | Phosphorylation | AMRSAAGTPVPSAHL HHHHHCCCCCCCHHH | 19.18 | 26657352 | |
1256 | Phosphorylation | AAGTPVPSAHLDCQA HCCCCCCCHHHHHHH | 28.67 | 26074081 | |
1345 | Sulfoxidation | SYLEEAVMHLDHSDP HHHHHHHHCCCCCCC | 3.15 | 30846556 | |
1368 | Acetylation | VMAQVRQKLFQFLQA HHHHHHHHHHHHHHC | 40.48 | 26051181 | |
1368 | Ubiquitination | VMAQVRQKLFQFLQA HHHHHHHHHHHHHHC | 40.48 | - | |
1380 | Phosphorylation | LQAEPHNSLGKAARR HHCCCCCHHHHHHHH | 35.15 | 22617229 | |
1383 | Ubiquitination | EPHNSLGKAARRLSL CCCCHHHHHHHHHHH | 44.13 | - | |
1389 | Phosphorylation | GKAARRLSLMLHGLV HHHHHHHHHHHCCCC | 15.21 | 28450419 | |
1399 | Phosphorylation | LHGLVTPSLP----- HCCCCCCCCC----- | 43.86 | 27251275 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EDC4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EDC4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DCP2_HUMAN | DCP2 | physical | 21672539 | |
DCP1B_HUMAN | DCP1B | physical | 21672539 | |
DCP1A_HUMAN | DCP1A | physical | 16364915 | |
DCP2_HUMAN | DCP2 | physical | 16364915 | |
FBLN1_HUMAN | FBLN1 | physical | 21988832 | |
GIT2_HUMAN | GIT2 | physical | 21988832 | |
YTDC1_HUMAN | YTHDC1 | physical | 21988832 | |
ABCF1_HUMAN | ABCF1 | physical | 22863883 | |
NELFB_HUMAN | NELFB | physical | 22863883 | |
DDX1_HUMAN | DDX1 | physical | 22863883 | |
DIM1_HUMAN | DIMT1 | physical | 22863883 | |
IF2B3_HUMAN | IGF2BP3 | physical | 22863883 | |
ILF2_HUMAN | ILF2 | physical | 22863883 | |
NMT1_HUMAN | NMT1 | physical | 22863883 | |
RFC4_HUMAN | RFC4 | physical | 22863883 | |
DCP1A_HUMAN | DCP1A | physical | 24778252 | |
DCP2_HUMAN | DCP2 | physical | 24778252 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6; SER-725; SER-844; SER-875; SER-879 ANDSER-887, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-125, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-676; THR-693; SER-725;SER-729; SER-741; SER-875; SER-879 AND SER-892, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723; SER-725; THR-727;SER-729; SER-871; SER-875 AND SER-879, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6; SER-725; SER-844; SER-875; SER-879 ANDSER-887, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-725; SER-809;THR-821; SER-844 AND SER-879, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-723; SER-729;SER-780 AND SER-871, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723; SER-725; THR-727;SER-729 AND SER-734, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729 AND SER-741, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1067 AND THR-1072, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-844, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693, AND MASSSPECTROMETRY. |